Introduction Despite important advances in many areas of hepatobiliary surgical practice
during the past decades, posthepatectomy liver failure (PHLF) still represents an important …

Background Chemotherapy-associated liver injury is a major cause for concern when
treating patients with colorectal liver metastases. The aim of this review was to determine the …

Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …

An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …

Post hepatectomy liver failure (PHLF) comprises of a conundrum of symptoms and signs
following major hepatic resections. The pathophysiology essentially revolves around …

Hepatic failure is a feared complication that accounts for up to 75% of mortality after
extensive liver resection. Despite improved perioperative care, the increasing complexity …

Colorectal cancer (CRC) is one of the intimidating causes of death around the world. CRC
originated from mutations of tumor suppressor genes, proto-oncogenes and DNA repair …

Selective internal radiation therapy (or radioembolization) by intra‐arterial injection of
radioactive yttrium‐90‐loaded microspheres is increasingly used for the treatment of …

Objective: We conducted a systematic review of the published literature to critically assess
benefits and risks of the use of preoperative chemotherapy in patients presenting with …

Oxaliplatin (OXA) is a third-generation platinum anticancer drug that is mainly used for the
treatment of metastatic colorectal cancer (CRC). Of note, hepatic sinusoidal obstruction …